Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma.

Garje R, An J, Greco A, Vaddepally RK, Zakharia Y.

Cancers (Basel). 2020 Jan 7;12(1). pii: E143. doi: 10.3390/cancers12010143. Review.

2.

Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review.

Greco A, Safi D, Swami U, Ginader T, Milhem M, Zakharia Y.

Cancers (Basel). 2019 Dec 5;11(12). pii: E1950. doi: 10.3390/cancers11121950. Review.

3.

Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment.

Garje R, An JJ, Sanchez K, Greco A, Stolwijk J, Devor E, Rustum Y, Zakharia Y.

Int J Mol Sci. 2018 Dec 1;19(12). pii: E3834. doi: 10.3390/ijms19123834. Review.

Supplemental Content

Loading ...
Support Center